Posts
February 24 2016
Amarantus BioScience Holdings Inc. announced the closing of their Registered Direct offering in the amount of $3,000,000. EG&S acted as counsel to the Investor.
February 22 2016
Client Alert: Trieme Medical, LLC v. Angioscore, Inc.
Recent federal circuit decision demonstrates the importance of having IP rights assigned for work prior to the effective date of consulting or employment agreements. Click here to read the full alert.
February 19 2016
ActiveCare Inc. announced the closing of their Restructure and Exchange offering in the amount of $5,900,000. EG&S acted as counsel to the Investor.
February 17 2016
Empire Resorts, Inc. announced the closing of their rights offering in the amount of $290,000,000. EG&S acted as counsel to Empire.
February 16 2016
Mast Therapeutics Inc. announced the closing of their Underwritten offering in the amount of $7,520,000. EG&S acted as counsel to the Underwriter.
February 10 2016
BioHiTech Global, Inc. announced the closing of their PIPE offering in the amount of $3,250,000. EG&S acted as counsel to the placement agent. .
February 09 2016
China Ceramics Co., Ltd. announced the closing of their Registered Direct offering in the amount of $900,000. EG&S acted as counsel to the Placement Agent.
February 04 2016
Cellular Biomedicine Group, Inc. announced the initial closing of a common stock PIPE offering in the amount of $5,000.000. The offering has a potential aggregate closing of $43,130,000 on or before April 15, 2016. EG&S acted as counsel to Cellular Biomedicine Group.